BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26926107)

  • 81. The p63 Gene Is Regulated by Grainyhead-like 2 (GRHL2) through Reciprocal Feedback and Determines the Epithelial Phenotype in Human Keratinocytes.
    Mehrazarin S; Chen W; Oh JE; Liu ZX; Kang KL; Yi JK; Kim RH; Shin KH; Park NH; Kang MK
    J Biol Chem; 2015 Aug; 290(32):19999-20008. PubMed ID: 26085095
    [TBL] [Abstract][Full Text] [Related]  

  • 82. EMT markers in lung adenocarcinoma pleural effusion spheroid cells.
    Giarnieri E; De Vitis C; Noto A; Roscilli G; Salerno G; Mariotta S; Ricci A; Bruno P; Russo G; Laurenzi A; Giovagnoli MR; Ciliberto G; Mancini R
    J Cell Physiol; 2013 Aug; 228(8):1720-6. PubMed ID: 23255165
    [TBL] [Abstract][Full Text] [Related]  

  • 83. An Epithelial-to-Mesenchymal Transcriptional Switch Triggers Evolution of Pulmonary Sarcomatoid Carcinoma (PSC) and Identifies Dasatinib as New Therapeutic Option.
    Manzotti G; Torricelli F; Benedetta D; Lococo F; Sancisi V; Rossi G; Piana S; Ciarrocchi A
    Clin Cancer Res; 2019 Apr; 25(7):2348-2360. PubMed ID: 30587547
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The multiverse nature of epithelial to mesenchymal transition.
    Simeone P; Trerotola M; Franck J; Cardon T; Marchisio M; Fournier I; Salzet M; Maffia M; Vergara D
    Semin Cancer Biol; 2019 Oct; 58():1-10. PubMed ID: 30453041
    [TBL] [Abstract][Full Text] [Related]  

  • 85. RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.
    Sakurai T; Isogaya K; Sakai S; Morikawa M; Morishita Y; Ehata S; Miyazono K; Koinuma D
    Oncogene; 2016 Sep; 35(38):5000-9. PubMed ID: 26923328
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte.
    Cicchini C; Amicone L; Alonzi T; Marchetti A; Mancone C; Tripodi M
    Liver Int; 2015 Feb; 35(2):302-10. PubMed ID: 24766136
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice.
    Yang Y; Ahn YH; Gibbons DL; Zang Y; Lin W; Thilaganathan N; Alvarez CA; Moreira DC; Creighton CJ; Gregory PA; Goodall GJ; Kurie JM
    J Clin Invest; 2011 Apr; 121(4):1373-85. PubMed ID: 21403400
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The role of cellular contact and TGF-beta signaling in the activation of the epithelial mesenchymal transition (EMT).
    Gasior K; Wagner NJ; Cores J; Caspar R; Wilson A; Bhattacharya S; Hauck ML
    Cell Adh Migr; 2019 Dec; 13(1):63-75. PubMed ID: 30296203
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A systematic approach identifies FOXA1 as a key factor in the loss of epithelial traits during the epithelial-to-mesenchymal transition in lung cancer.
    Wang H; Meyer CA; Fei T; Wang G; Zhang F; Liu XS
    BMC Genomics; 2013 Oct; 14():680. PubMed ID: 24093963
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Polymorphisms in genes related to epithelial-mesenchymal transition and risk of non-small cell lung cancer.
    Xie K; Ye Y; Zeng Y; Gu J; Yang H; Wu X
    Carcinogenesis; 2017 Oct; 38(10):1029-1035. PubMed ID: 28968839
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Krüppel-like Transcription Factor KLF10 Suppresses TGFβ-Induced Epithelial-to-Mesenchymal Transition via a Negative Feedback Mechanism.
    Mishra VK; Subramaniam M; Kari V; Pitel KS; Baumgart SJ; Naylor RM; Nagarajan S; Wegwitz F; Ellenrieder V; Hawse JR; Johnsen SA
    Cancer Res; 2017 May; 77(9):2387-2400. PubMed ID: 28249899
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
    Snyder EL; Watanabe H; Magendantz M; Hoersch S; Chen TA; Wang DG; Crowley D; Whittaker CA; Meyerson M; Kimura S; Jacks T
    Mol Cell; 2013 Apr; 50(2):185-99. PubMed ID: 23523371
    [TBL] [Abstract][Full Text] [Related]  

  • 93. C/EBPɑ is crucial determinant of epithelial maintenance by preventing epithelial-to-mesenchymal transition.
    Lourenço AR; Roukens MG; Seinstra D; Frederiks CL; Pals CE; Vervoort SJ; Margarido AS; van Rheenen J; Coffer PJ
    Nat Commun; 2020 Feb; 11(1):785. PubMed ID: 32034145
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Epithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients.
    Reka AK; Chen G; Jones RC; Amunugama R; Kim S; Karnovsky A; Standiford TJ; Beer DG; Omenn GS; Keshamouni VG
    Carcinogenesis; 2014 Jun; 35(6):1292-300. PubMed ID: 24510113
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Selective inhibition of tumor oncogenes by disruption of super-enhancers.
    Lovén J; Hoke HA; Lin CY; Lau A; Orlando DA; Vakoc CR; Bradner JE; Lee TI; Young RA
    Cell; 2013 Apr; 153(2):320-34. PubMed ID: 23582323
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor-1 (TTF-1)-negative pulmonary adenocarcinoma.
    Kunii R; Jiang S; Hasegawa G; Yamamoto T; Umezu H; Watanabe T; Tsuchida M; Hashimoto T; Hamakubo T; Kodama T; Sasai K; Naito M
    Histopathology; 2011 Feb; 58(3):467-76. PubMed ID: 21348892
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Integrated analysis reveals candidate genes and transcription factors in lung adenocarcinoma.
    Chen B; Gao S; Ji C; Song G
    Mol Med Rep; 2017 Dec; 16(6):8371-8379. PubMed ID: 28983631
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages.
    Mimae T; Okada M; Hagiyama M; Miyata Y; Tsutani Y; Inoue T; Murakami Y; Ito A
    Clin Cancer Res; 2012 Feb; 18(4):945-55. PubMed ID: 22190591
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.
    Tan TZ; Miow QH; Miki Y; Noda T; Mori S; Huang RY; Thiery JP
    EMBO Mol Med; 2014 Oct; 6(10):1279-93. PubMed ID: 25214461
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype.
    Chang HW; Lin ZM; Wu MJ; Wang LY; Chow YH; Jiang SS; Ch'ang HJ; Chang VH
    PLoS One; 2017; 12(4):e0175586. PubMed ID: 28419107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.